Voyager Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Voyager Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2015 to Q2 2024.
  • Voyager Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $4.91M, a 49.8% increase year-over-year.
  • Voyager Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $16.4M, a 76.4% increase year-over-year.
  • Voyager Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $11.7M, a 164% increase from 2022.
  • Voyager Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $4.45M, a 83.6% increase from 2021.
  • Voyager Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $2.42M, a 74.1% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $16.4M $4.91M +$1.63M +49.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $14.7M $4.87M +$3M +161% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $11.7M $3.15M +$2.2M +231% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $9.52M $3.43M +$247K +7.76% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $9.28M $3.28M +$3M +1070% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $6.28M $1.86M +$1.83M +5913% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $4.45M $952K +$945K +13500% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $3.5M $3.18M +$3.17M +35256% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $327K $280K +$1.82M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$1.49M $31K -$3.91M -99.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $2.42M $7K -$7.8M -99.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $10.2M $9K -$1.08M -99.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $11.3M -$1.54M -$1.84M -612% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $13.1M $3.94M +$3.77M +2218% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $9.36M $7.8M +$6.61M +554% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-07
Q3 2020 $2.75M $1.08M -$1.72M -61.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $4.47M $300K -$1.66M -84.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $6.13M $170K -$1.95M -92% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $8.08M $1.19M +$565K +89.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-08
Q3 2019 $7.52M $2.8M +$1.94M +226% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $5.57M $1.96M +$1.81M +1184% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $3.76M $2.12M +$1.14M +115% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $2.63M $629K +$79K +14.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $2.55M $858K +$849K +9433% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $1.7M $153K +$195K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $1.5M $987K +$339K +52.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $1.17M $550K +$1.03M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-03
Q3 2017 $139K $9K -$1.06M -99.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $1.2M -$42K -$325K -115% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $1.53M $648K +$369K +132% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $1.16M -$476K Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $1.07M +$970K +951% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $283K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $279K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q3 2015 $102K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.